Fresenius | FRE - Loan Capital


Fresenius reported EUR9.22B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Akzo Nobel EUR 4.76B 1.09B Mar/2026
Alcon AG USD 4.16B 434M Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
BASF EUR 18.48B 447M Dec/2025
Bayer EUR 30.68B 1.15B Mar/2026
Beiersdorf EUR 117M 15M Dec/2025
DaVita Healthcare Partners USD 10.51B 349.61M Mar/2026
Demant DKK 18.98B 3.71B Dec/2025
E.ON EUR 36.53B 2.47B Mar/2026
Essilor EUR 9.46B 92M Dec/2025
Fresenius EUR 9.22B 1.58B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Getinge SEK 9.09B 167M Jun/2026
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GN Store Nord DKK 8.1B 790M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Philips EUR 6.89B 43M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
RWE EUR 16.43B 917M Mar/2026
Sanofi EUR 13.84B 1.88B Mar/2026
Smith & Nephew USD 3.3B 22M Dec/2025